Optimal timing and treatment strategies for newborn complex congenital heart disease surgery
Official title: Multicenter Randomized Controlled Trial (RCT) and Efficacy Evaluation System Study on Surgical Innovation Strategies for Neonatal Complex Congenital Heart Disease
Run by Central China Fuwai Hospital of Zhengzhou University · NCT07363538 · Data updated 2026-11-12
This project will test whether doing heart surgery within the first week of life versus after day seven leads to fewer deaths and complications for newborns with complex congenital heart defects.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | Any age to 7 Days |
| Sex | All |
| Enrollment | 738 (estimated) |
| Sponsor | Central China Fuwai Hospital of Zhengzhou University Academic / other |
| Locations | 12 sites (Beijing, Beijing Municipality and 11 other locations) |
| Status | Recruiting |
| Started | December 1, 2025 |
| Main results expected | January 31, 2029 |
| Study ends | January 31, 2029 |
| Registry record updated | January 23, 2026 |
| Trial ID | NCT07363538 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Term neonates (≥36 weeks gestation) weighing ≥2.5 kg who are diagnosed by pre-admission echocardiography with TAPVC, CoA/IAA, TGA, PA/IVS, or severe PS and whose families consent to one year of follow-up are ideal candidates.
✕Probably not a fit
Preterm infants (<36 weeks), low-birth-weight babies (<2.5 kg), those with severe extracardiac anomalies or very complex cardiac malformations, or neonates needing emergency unstable preoperative support are unlikely to benefit from this protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a multicenter randomized controlled trial that will assign neonates with selected complex congenital heart defects to surgery either before day seven or after day seven of life. The trial builds on a national multicenter surgical database and a prenatal-postnatal integrated diagnosis and treatment model, and includes standardized perioperative protocols and one year of follow-up. The investigators will also develop comprehensive treatment strategies for critically ill neonatal patients and create an efficacy evaluation system based on trial data. The program intends to roll out the evaluation system nationwide to reduce perioperative mortality and non-recovery discharge rates.
Why it matters
Potential benefit: If successful, the approach could substantially lower perioperative deaths and non-recovery discharges and raise the overall standard of neonatal CCHD care in China.
How similar studies have gone: Randomized trials directly comparing neonatal cardiac surgery timing are limited and prior evidence is mixed, so this large multicenter RCT represents a relatively novel approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Neonates diagnosed with TAPVC, CoA/IAA, TGA, PA/IVS, or severe PS via pre-admission cardiac echocardiography; 2. Patients and families demonstrating high compliance, willing to sign informed consent forms and agree to complete one year of follow-up and related examinations. Exclusion Criteria: 1. Preterm infant (gestational age \< 36 weeks at birth); 2. Low birth weight (weight \< 2.5 kg); 3. Concurrent severe extracardiac anomalies or complex cardiac malformations; 4. Preoperative respiratory or circulatory instability requiring emergency surgery.
Where it's running
-
Fuwai Hospital, Chinese Academy of Medical Sciences
Beijing, Beijing Municipality, China Recruiting -
Central China Fuwai Hospital of Zhengzhou University
Zhengzhou, Henan, China Recruiting -
Children's Hospital of Chongqing Medical University
Chongqing, Chongqing Municipality, China Not yet recruiting -
Guangzhou Women and Children's Medical Center, Guangzhou Medical University
Guangzhou, Guangdong, China Not yet recruiting -
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Wuhan, Hubei, China Not yet recruiting -
The Second Xiangya Hospital of Central South University
Changsha, Hunan, China Not yet recruiting
Show 6 more locations
-
Children's Hospital Affiliated to Nanjing Medical University
Nanjing, Jiangsu, China Not yet recruiting -
Qingdao Women and Children's Hospital
Qingdao, Shandong, China Not yet recruiting -
Shanghai Children's Medical Center (SCMC) Affiliated to Shanghai Jiao Tong University School of Medicine
Shanghai, Shanghai Municipality, China Not yet recruiting -
The First Affiliated Hospital of Air Force Medical University (Xijing Hospital)
Xi’an, Shanxi, China Not yet recruiting -
West China Second Hospital of Sichuan University
Chengdu, Sichuan, China Not yet recruiting -
Children's Hospital Zhejiang University School of Medicine
Hangzhou, Zhejiang, China Not yet recruiting
Study contacts
- Study coordinator: Song Shubo Shubo Song
- Email: songshubo2008@126.com
- Phone: 13523535453
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
12-week home heart rehabilitation program for children with complex congenital heart disease.
This program will test whether a 12-week remote cardiac rehabilitation program can improve heart and lung fitness and quality of life in children aged 8–18 with complex congenital heart disease.
-
Surgical techniques and outcomes across the lifespan in congenital heart disease in China
See which surgical factors and care patterns affect recovery after heart surgery for people with complex congenital heart disease in China.
-
Support for parents of children with congenital heart disease during surgery
This study is testing a new support program to see if it can help reduce stress for parents of babies with congenital heart disease during their surgery.
-
Evaluation of a heart valve for patients with pulmonary valve dysfunction
This study tests a new heart valve to see if it can safely help people with problems in their pulmonary valve or right ventricular outflow tract.
-
Adapting and testing PEN-Plus in Zambian primary care
Aiming to see if the PEN-Plus package can be adapted and used in two Zambian hospitals to better manage chronic diseases like heart disease, diabetes, hypertension, and sickle cell in primary care.
-
Wireless NIRS Sensor Use in the NICU for Monitoring on Neonates
A wireless NIRS sensor is tested on infants in the NICU to see how well it stays on and how it notes brain signals when used alongside standard wired sensors.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.